By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innate Pharma 

Grand Pré
119/121 Ancien Chemin De Cassis
Marseille      France
Phone: 33-0-4-96-19-05-50 Fax: 33-04-96-19-05-55


Company News
Innate Pharma (IPH.PA ) : Orphan Drug Designation In The European Union For Iph4102 8/27/2014 7:36:33 AM
Enzo Biochem (ENZ) Unit Partners With Innate Pharma (IPH.PA ) To Validate Key System For Antibody Drug Conjugate Development 5/30/2014 9:28:45 AM
Highlights From Innate Pharma (IPH.PA )'s R&D Update Today In New York 4/10/2014 7:42:56 AM
Innate Pharma (IPH.PA ) : Start Of Cohort Expansion Of Phase I Trial With Lirilumab And Nivolumab In Selected Solid Tumors 3/31/2014 10:08:44 AM
Innate Pharma (IPH.PA ): R&D Update On April 10, 2014 In New York 3/17/2014 9:05:10 AM
Innate Pharma (IPH.PA ): Raises [Eur]20.3 Million In A Private Placement Subscribed Entirely By US-Based Specialist Investors 11/20/2013 9:02:18 AM
Innate Pharma (IPH.PA ): Launch of IND-Enabling Studies for IPH4102 11/8/2013 9:38:29 AM
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2 4/12/2013 9:22:19 AM
Innate Pharma (IPH.PA ) Release: Annual Results for 2012: Significant Advance for Four Drug Candidates and Strong Cash Position 3/5/2013 9:24:25 AM
Innate Pharma (IPH.PA ): Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced 12/19/2012 8:45:39 AM